1263-89-4: Neomycin Sulfate EP Impurity E
Also known as Aminosidine Sulfate, it is an impurity present in Neomycin that is bactericidal in vitro against a wide variety of gram-negative and gram-positive organisms, including some that are streptomycin-resistant, and also it is utilized in dermatological therapy.
Additional information on CAS 1263-89-4
VE006931
1263-89-4
C23H45N5O14 . H2SO4
615.63 . 98.07
Neomycin
(2S, 3S, 4R, 5R, 6R)-5-amino-2-(aminomethyl)-6-(((2R, 3S, 4R, 5S)-5-(((1R, 2R, 3S, 5R, 6S)-3, 5-diamino-2-(((2S, 3R, 4R, 5S, 6R)-3-amino-4, 5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3, 4-diol sulfate
Aminosidine Sulfate
Szychowski, Janek, et al. “Inhibition of Aminoglycoside-Deactivating Enzymes APH(3?)-IIIa and AAC(6?)-Ii by Amphiphilic Paromomycin O2??-Ether Analogues.” ChemMedChem, vol. 6, no. 11, Sept. 2011, pp. 1961–66, https://doi.org/10.1002/cmdc.201100346 Kile, Roy L. “USE of NEOMYCIN in DERMATOLOGY.” JAMA: The Journal of the American Medical Association, vol. 148, no. 5, Feb. 1952, p. 339, https://doi.org/10.1001/jama.1952.02930050011003.?
In-stock
Other products related to neomycin
Name of Impurity | Catalogue No. | |
---|---|---|
Neomycin Sulfate | VL4260001 | View CAS 1405-10-3 |
Neomycin Sulfate EP Impurity B | VE006928 | View |
Neomycin Sulfate EP Impurity C | VE006929 | View CAS 66-86-4 |
Neomycin Sulfate EP Impurity D | VE006930 | View CAS 534-47-4 // 18685-97-7 |
Neomycin Sulfate EP Impurity F | VE006932 | View CAS 51795-47-2 |
Neomycin Sulfate EP Impurity G | VE006933 | View |
Neomycin sulfate EP Impurity A | VL212001 | View CAS 3947-65-7 |